US 8513005
DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence
granted A61KA61K2039/53A61K39/12
Quick answer
US patent 8513005 (DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/53, A61K39/12, A61K39/285, A61P